Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hologic hoists Q3 top-line by 33% but lowers Q4/FY outlook

This article was originally published in Clinica

Executive Summary

Women’s health specialist Hologic is still reaping the rewards of its $3.7bn acquisition of Gen-Probe, after it posted high double-digit growth for yet another quarter. Hologic attributed the 33% increase in its third fiscal quarter revenue, at $626.1m, to the inclusion of revenue from the molecular diagnostics business which it acquired in May 2012 (, 1 May 2012).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts